Mason Street Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-766,766
| Closed | -$28.2M | – | 901 |
|
|
2020
Q4 | $28.2M | Sell |
766,766
-55,856
| -7% | -$2.05M | 0.48% | 28 |
|
|
2020
Q3 | $28.6M | Sell |
822,622
-13,232
| -2% | -$464K | 0.56% | 25 |
|
|
2020
Q2 | $25.9M | Buy |
835,854
+3,624
| +0.4% | +$123K | 0.52% | 32 |
|
|
2020
Q1 | $25.8M | Hold |
832,230
| – | – | 0.59% | 24 |
|
|
2019
Q4 | $30.9M | Buy |
832,230
+1,684
| +0.2% | +$60K | 0.59% | 25 |
|
|
2019
Q3 | $28.3M | Sell |
830,546
-3,994
| -0.5% | -$145K | 0.58% | 31 |
|
|
2019
Q2 | $34.3M | Sell |
834,540
-268
| -0% | -$10.6K | 0.72% | 17 |
|
|
2019
Q1 | $33.6M | Sell |
834,808
-24,162
| -3% | -$968K | 0.68% | 20 |
|
|
2018
Q4 | $35.6M | Sell |
858,970
-9,619
| -1% | -$399K | 0.86% | 12 |
|
|
2018
Q3 | $36.3M | Buy |
868,589
+3,561
| +0.4% | +$137K | 0.75% | 15 |
|
|
2018
Q2 | $29.8M | Sell |
865,028
-8,970
| -1% | -$307K | 0.65% | 21 |
|
|
2018
Q1 | $29.4M | Sell |
873,998
-1,115
| -0.1% | -$38.3K | 0.67% | 18 |
|
|
2017
Q4 | $30.1M | Buy |
875,113
+1,929
| +0.2% | +$65.8K | 0.67% | 21 |
|
|
2017
Q3 | $29.6M | Buy |
873,184
+186
| +0% | +$5.98K | 0.7% | 17 |
|
|
2017
Q2 | $27.8M | Buy |
872,998
+6,079
| +0.7% | +$192K | 0.7% | 17 |
|
|
2017
Q1 | $28.1M | Sell |
866,919
-8,031
| -0.9% | -$253K | 0.72% | 17 |
|
|
2016
Q4 | $27M | Buy |
874,950
+10,083
| +1% | +$308K | 0.73% | 20 |
|
|
2016
Q3 | $27.8M | Buy |
864,867
+3,855
| +0.4% | +$129K | 0.79% | 15 |
|
|
2016
Q2 | $28.8M | Buy |
861,012
+11,887
| +1% | +$379K | 0.84% | 15 |
|
|
2016
Q1 | $23.9M | Sell |
849,125
-859
| -0.1% | -$24.5K | 0.73% | 18 |
|
|
2015
Q4 | $26M | Buy |
849,984
+8,927
| +1% | +$281K | 0.82% | 15 |
|
|
2015
Q3 | $25.1M | Buy |
841,057
+5,353
| +0.6% | +$172K | 0.85% | 13 |
|
|
2015
Q2 | $26.6M | Buy |
835,704
+3,781
| +0.5% | +$123K | 0.81% | 12 |
|
|
2015
Q1 | $27.5M | Sell |
831,923
-2,105,946
| -72% | -$67M | 0.83% | 12 |
|
|
2014
Q4 | $86.8M | Buy |
2,937,869
+467,967
| +19% | +$13.4M | 0.61% | 15 |
|
|
2014
Q3 | $69.3M | Buy |
2,469,902
+185,199
| +8% | +$5.2M | 0.54% | 18 |
|
|
2014
Q2 | $64.3M | Buy |
2,284,703
+144,322
| +7% | +$4.11M | 0.5% | 23 |
|
|
2014
Q1 | $65.2M | Sell |
2,140,381
-21,786
| -1% | -$650K | 0.53% | 17 |
|
|
2013
Q4 | $62.8M | Buy |
2,162,167
+267,488
| +14% | +$7.78M | 0.51% | 18 |
|
|
2013
Q3 | $51.6M | Sell |
1,894,679
-525,021
| -22% | -$14.3M | 0.59% | 19 |
|
|
2013
Q2 | $64.3M | Buy |
+2,419,700
| New | +$66.9M | 0.71% | 18 |
|
Other funds holding PFE
Mason Street Advisors's PFE Position: Q1 2021 in Review
Mason Street Advisors sold out of Pfizer (PFE) in Q1 2021, closing a stake of 766,766 shares — an estimated $28.2M sold.
Mason Street Advisors first reported a position in PFE in Q2 2013 and held it in 31 quarters. The position peaked at $86.8M in Q4 2014. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- Mason Street Advisors reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 766,766 Pfizer shares in Q1 2021, an estimated $28.2M.
- Mason Street Advisors first reported a position in Pfizer in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Pfizer position peaked at $86.8M in Q4 2014.
- 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.